Transforming growth factor-beta-induced factor 1 (TGIF1) (TGIF1)

Transforming growth factor-beta-induced factor 1 (TGIF1) is a homeodomain-containing transcriptional corepressor that plays a central role in modulating the TGF-beta and Nodal signaling pathways (UniProt Q15582). By binding to SMAD2/3 complexes and recruiting histone deacetylases (HDACs), TGIF1 effectively silences the expression of genes that would otherwise be activated by TGF-beta signaling (PubMed: 10391249). This regulatory function is critical during embryogenesis, particularly for the induction of the ventral forebrain; consequently, mutations in TGIF1 are a primary cause of holoprosencephaly type 4 (HPE4) (NIH: GeneReviews). In oncology, TGIF1 is frequently overexpressed and acts as a pro-tumorigenic factor by promoting the epithelial-mesenchymal transition (EMT), enhancing cell migration, and facilitating immune evasion (PubMed: 25670011). Despite its clear involvement in disease progression, TGIF1 remains a challenging therapeutic target because it lacks a defined small-molecule binding pocket and functions through complex protein-protein interactions. Current therapeutic strategies often focus on indirect modulation of the TGIF1-related signaling network through TGF-beta receptor inhibitors or HDAC inhibitors, though direct TGIF1 antagonists are an area of active early-stage research.

Other names

TGIFHPE4Transforming growth factor-beta-induced factorHomeobox protein TGIF1

TGIF1 acts as a transcriptional corepressor by binding to SMAD2/3 complexes and recruiting histone deacetylases (HDACs) to inhibit TGF-beta and Nodal signaling pathways.